The secondary outcomes included TG, HDL-C, LDL-C, HbA1c, fasting blood glucose, fasting serum insulin, Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), SBP, and DBP. This evidence concerns the gene INS and Insulin resistance.